0

FAUC 213

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP337972471
CAS337972-47-1
Structure
MDL NumberMFCD06798338
Molecular Weight326.82
InChI KeyDTRXURJDKOYCCD-UHFFFAOYSA-N
Description≥98% (HPLC), solid
SolubilityDMSO: ~24 mg/mL (with warming up to 60 °C); H2O: insoluble
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size5MG, 25MG
Storage Conditions2-8°C
1

Blocking alpha2A Adrenoceptors, but Not Dopamine Receptors, Augments Bupropion-Induced Hypophagia in Rats

Sanna K Janhunen, Susanne E la Fleur, Roger A H Adan

Obesity (Silver Spring). 2013 Dec;21(12):E700-8.

PMID: 23894096

1

FAUC 213, a Highly Selective Dopamine D4 Receptor Full Antagonist, Exhibits Atypical Antipsychotic Properties in Behavioural and Neurochemical Models of Schizophrenia

Frank Boeckler, Holger Russig, Weining Zhang, Stefan Löber, John Schetz, Harald Hübner, Boris Ferger, Peter Gmeiner, Joram Feldon

Psychopharmacology (Berl). 2004 Aug;175(1):7-17.

PMID: 15007532

1

Rationally Based Efficacy Tuning of Selective Dopamine d4 Receptor Ligands Leading to the Complete Antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213)

S Löber, H Hübner, W Utz, P Gmeiner

J Med Chem. 2001 Aug 16;44(17):2691-4.

PMID: 11495580

1

Synthesis, Radiofluorination, and in Vitro Evaluation of pyrazolo[1,5-a]pyridine-based Dopamine D4 Receptor Ligands: Discovery of an Inverse Agonist Radioligand for PET

Olaf Prante, Rainer Tietze, Carsten Hocke, Stefan Löber, Harald Hübner, Torsten Kuwert, Peter Gmeiner

J Med Chem. 2008 Mar 27;51(6):1800-10.

PMID: 18307287

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode